IJU Case Reports (Nov 2022)

A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy

  • Nami Tomiyama,
  • Taku Naiki,
  • Aya Naiki‐Ito,
  • Tatsuya Kawai,
  • Toshiki Etani,
  • Masakazu Gonda,
  • Maria Aoki,
  • Toshiharu Morikawa,
  • Yosuke Sugiyama,
  • Takahiro Yasui

DOI
https://doi.org/10.1002/iju5.12519
Journal volume & issue
Vol. 5, no. 6
pp. 474 – 478

Abstract

Read online

Introduction The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not been established. Case presentation Herein, we describe a 52‐year‐old Asian male who presented with a right adrenal metastasis of non‐small cell lung cancer 8 months after immunochemotherapy and surgical resection of the lung. He underwent combined systemic treatment and a laparoscopic right adrenalectomy; however, after 9 months, a metachronous left adrenal metastasis emerged. A subsequent laparoscopic left adrenalectomy and systemic treatment led to long‐term progression‐free survival. Conclusion The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non‐small cell lung cancer may extend the prognosis.

Keywords